Hubbry Logo
NeotameNeotameMain
Open search
Neotame
Community hub
Neotame
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Neotame
Neotame
from Wikipedia
Neotame
Ball-and-stick model of the neotame molecule
Names
Systematic IUPAC name
(3S)-3-[(3,3-Dimethylbutyl)amino]-4-{[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino}-4-oxobutanoic acid
Other names
E961; N-(N-(3,3-Dimethylbutyl)-L-α-aspartyl)-L-phenylalanine 1-methyl ester
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
ECHA InfoCard 100.109.344 Edit this at Wikidata
E number E961 (glazing agents, ...)
UNII
  • InChI=1S/C20H30N2O5/c1-20(2,3)10-11-21-15(13-17(23)24)18(25)22-16(19(26)27-4)12-14-8-6-5-7-9-14/h5-9,15-16,21H,10-13H2,1-4H3,(H,22,25)(H,23,24)/t15-,16-/m0/s1 ☒N
    Key: HLIAVLHNDJUHFG-HOTGVXAUSA-N ☒N
  • InChI=1/C20H30N2O5/c1-20(2,3)10-11-21-15(13-17(23)24)18(25)22-16(19(26)27-4)12-14-8-6-5-7-9-14/h5-9,15-16,21H,10-13H2,1-4H3,(H,22,25)(H,23,24)/t15-,16-/m0/s1
    Key: HLIAVLHNDJUHFG-HOTGVXAUBG
  • CC(C)(C)CCN[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)OC
Properties
C20H30N2O5
Molar mass 378.469 g·mol−1
Appearance white powder[1]
Melting point 80.9–83.4 °C (177.6–182.1 °F; 354.0–356.5 K)[1]
12.6 g/kg at 25 °C[2]
Hazards
NFPA 704 (fire diamond)
NFPA 704 four-colored diamondHealth 0: Exposure under fire conditions would offer no hazard beyond that of ordinary combustible material. E.g. sodium chlorideFlammability 1: Must be pre-heated before ignition can occur. Flash point over 93 °C (200 °F). E.g. canola oilInstability 0: Normally stable, even under fire exposure conditions, and is not reactive with water. E.g. liquid nitrogenSpecial hazards (white): no code
0
1
0
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Neotame, also known by the brand name Newtame,[3] is a non-caloric artificial sweetener and aspartame analog.[2] By mass, it is 7,000 to 13,000 times sweeter than sucrose.[3] It has no notable off-flavors when compared to sucrose. It enhances original food flavors. It can be used alone, but is often mixed with other sweeteners to increase their individual sweetness (i.e. synergistic effect) and decrease their off-flavors (e.g. saccharin). It is chemically somewhat more stable than aspartame. Its use can be cost effective in comparison to other sweeteners as smaller amounts of neotame are needed.[2]

It is suitable for use in carbonated soft drinks, yogurts, cakes, drink powders, and bubble gums among other foods. It can be used as a table top sweetener for hot drinks like coffee. It covers bitter tastes (e.g. caffeine).[2]

In 2002, FDA approved it as a non-nutritive sweetener and flavor enhancer within the United States in foods generally, except meat and poultry.[3] In 2010, it was approved for use in foods within the European Union with the E number E961.[4] It has also been approved as an additive in many other countries outside US and EU.[2]

Its metabolism is fast and is not retained in the body. Methanol forms in its metabolism. Only trace amounts of neotame are added to foods, so the amount of methanol is insignificant for health. It is safe for type 2 diabetics and those with phenylketonuria.[5][1]

French scientists Claude Nofre and Jean-Marie Tinti invented neotame.[2] In 1992, they filed a United States patent, which was granted in 1996.[6]

Safety

[edit]

In US and EU, the acceptable daily intake (ADI) of neotame for humans is 0.3 and 2 mg per kg of bodyweight (mg/kg bw), respectively. NOAEL for humans is 200 mg/kg bw per day within EU.[3][1] Estimated possible daily intakes from foods are well below ADI levels. Ingested neotame can form phenylalanine, but in normal use of neotame, this is not significant to those with phenylketonuria. It also has no adverse effects in type 2 diabetics. It is not considered to be carcinogenic or mutagenic.[5][1] The Center for Science in the Public Interest has ranked neotame as safe.[7]

Sweetness

[edit]

Water solutions of neotame that are equivalent in sweetness to sucrose water solutions increase logarithmically in relative sweetness as the sucrose concentration of a comparably sweet sucrose solution increases until a plateau is reached. Maximum sweetness is reached at neotame solution concentrations that are relatively as sweet as a water solution that is 15.1 percentage sucrose by weight, i.e., at 15.1 sucrose equivalence % (SE%). For comparison, acesulfame K, cyclamate and saccharin reach their maximum sweetness at 11.6 SE%, 11.3 SE% and 9 SE%, respectively.[2]

Neotame is a high-potency sweetener, and it is 7,000 to 13,000 times sweeter than table sugar.[3] Neotame contains flavor-enhancing properties, and compared to sucrose or aspartame, it has a relatively lower cost per sweetness factor.[8]

Chemistry

[edit]

Structure

[edit]

Neotame is formally a secondary amine of 3,3-dimethylbutanal and aspartame. The latter is a dipeptide of phenylalanine and aspartic acid. Neotame has 2 stereocenters and 4 stereoisomers. Sweetness is due to the (2S),(3S)-stereoisomer.[9]

Spectroscopy

[edit]

Neotame NMR spectroscopy identifies its structure with a peak at 0.84 ppm indicating the three methyl groups on the carbon chain bonded to the nitrogen.[10]

Proton NMR spectroscopy of neotame[10]

Synthesis

[edit]

Neotame is synthesized from aspartame through a reductive alkylation with 3,3-dimethylbutyraldehyde in a palladium catalyst with methanol.[11] The stereochemistry of aspartame is conserved during the synthesis and therefore, neotame and aspartame have the same stereochemistry. (2S),(3S)-stereoisomer of aspartame is needed to synthesize the (2S),(3S)-stereoisomer of neotame.[11]

Properties and reactivity

[edit]
Neotame, a fine white powder, in a jar
Neotame

Neotame has similar stability as aspartame, but has greater stability especially in heated and dairy foods.[3] Increased temperature, moisture or pH increase losses, and are the main relevant properties of a food when considering the stability of neotame. For example, about 90% of original neotame remains after 8 weeks of storage in pH 3.2 beverages. Neotame is especially stable as a dry powder at room temperature and humidity even if mixed with glucose or maltodextrin, and is relatively inert in foods with reducing sugars like fructose.[2]

Unlike aspartame, neotame doesn't form diketopiperazines via intra-molecular cyclization due to its N-alkyl substitution with 3,3-dimethylbutyl. This increases its heat stability.[3]

Over 1000 g of neotame dissolves in 1 kg of ethanol at 15 °C. At 15 °C the solubility of neotame is 10.6 g/kg in water and 43.6 g/kg in ethyl acetate. At 25 °C the solubilities are 12.6 g/kg and 77.0 g/kg, respectively. At 40 °C the solubilities are 18.0 g/kg and 238 g/kg, respectively. At 50 °C the solubilities are 25.2 g/kg and 872 g/kg, respectively.[2] Neotame is acidic and its 0.5 wt% solution has a pH of 5.80.[1]

Manufacture

[edit]

Industrially neotame is made from 3,3-dimethylbutanal and aspartame via reductive amination.[2] They are dissolved in methanol, palladium on carbon catalyst is added, air is replaced with hydrogen and the reaction is carried out in room temperature under pressure for a few hours. Catalyst is filtered out. This can be aided with diatomaceous earth. Methanol is distilled followed by addition of water. The mixture is cooled for a few hours, neotame is isolated via centrifugation, washed with water and vacuum dried. Neotame is milled to suitable size.[1]

Metabolism

[edit]
Neotame de-esterification via hydrolysis. CH3OH is methanol.

In humans and many other animals like dogs, rats and rabbits, neotame is rapidly but incompletely absorbed. Its metabolites are not retained or concentrated in specific tissues.[1]

In humans at oral doses of about 0.25 mg per kg of bodyweight (mg/kg bw), about 34% is absorbed into blood. Pharmacokinetics of oral doses of 0.1–0.5 mg/kg bw are somewhat linear, and at such doses, maximum neotame concentration in blood plasma is reached after about 0.5 hours with a half-life of about 0.75 hours. In blood and in body in general, non-specific esterases degrade neotame to de-esterified neotame and methanol, which is the main metabolic pathway in humans. De-esterified neotame has a plasma half-life of about 2 hours, and is the main metabolite in plasma.[1]

In humans, over 80% of the original oral dose is excreted in feces and urine within 48 hours and the rest later. About 64% of the original dose is excreted in feces mostly as metabolites. Major metabolite in feces is the de-esterified neotame. Over 1% of the original dose is excreted in feces as N-(3,3-dimethylbutyl)-L-aspartyl - L - phenylalanine. Over 1% is excreted in urine as carnitine conjugate of 3,3-dimethylbutyric acid. Other minor metabolites form.[1]

The major metabolic pathway leads to N-(3,3-dimethylbutyl)-L-aspartyl - L - phenylalanine with a side product of methanol, and the minor pathway happens when the N-(3,3-dimethylbutyl)-L-aspartyl - L - phenylalanine is oxidized into 3,3-dimethylbutyric acid. The side products for the minor pathway is methanol, aspartic acid and phenylalanine.[12]

Methanol from neotame metabolism is insignificant at regulated levels used in foods and in comparison to methanol naturally found in foods.[1]

Patent

[edit]

The patent covering the neotame molecule in the US, 5,480,668,[6] was originally set to expire 7 November 2012, but was extended for 973 days by the U.S. Patent and Trademark Office. The patent expired on 8 July 2015.[13]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Neotame is a non-nutritive artificial , chemically derived from , that is approximately 7,000 to 13,000 times sweeter than and approved by the U.S. (FDA) in 2002 for use as a general-purpose and flavor enhancer in a wide variety of s, excluding and . Developed in the by the Company through collaboration with French chemists Claude Nofre and Jean-Marie Tinti, neotame was designed to address limitations of , such as instability in heat, by incorporating an additional 3,3-dimethylbutyl group on its aspartyl residue, resulting in a structure (N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ) that enhances its potency and thermal stability. Sold under the brand name Newtame®, it is about 30 to 40 times sweeter than itself and is metabolized differently in the body, producing minimal , which makes it safe for individuals with (PKU). Neotame's high intensity allows for use in very small quantities in products such as soft drinks, baked goods, items, frozen desserts, , and sauces, where it provides sweetness without contributing calories and can mask off-flavors when blended with other sweeteners like or . Its heat stability enables applications in cooking and baking, unlike , and it has been approved in the since 2010 following safety evaluations by the (EFSA). Safety assessments, including over 110 studies reviewed by the FDA, have established neotame as for the general population, including children, pregnant women, and those with , with an (ADI) of 0.3 mg/kg body weight per day; the FDA's review found no adverse effects. In 2025, EFSA re-evaluated neotame, reaffirming its safety and increasing the ADI to 10 mg/kg body weight per day for use in the EU. It received a "" rating from the Center for in the Public Interest (CSPI) due to its low metabolic impact and lack of adverse effects in toxicological tests. Despite its approvals, neotame remains less commonly used than other sweeteners. A 2024 study suggested potential adverse effects on the gut and , raising questions about long-term gastrointestinal impacts. Additionally, recent studies have identified its presence in disposable e-cigarettes, raising questions about inhalation exposure.

Introduction

Overview

Neotame is a non-caloric artificial derived from , chemically known as N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl . It provides intense sweetness without contributing calories, making it suitable for low- and no-calorie and beverage formulations. By , neotame is 7,000 to 13,000 times sweeter than , allowing for minimal usage levels in products. This high potency contributes to its cost-effectiveness compared to other sweeteners, as smaller quantities achieve equivalent sweetness. Neotame offers key advantages including improved heat stability compared to (stable during processing at around 88°C), conditions across 3–7, and in products, enabling its use in baked goods, beverages, and processed without significant degradation. Additionally, it possesses flavor-enhancing properties that improve the taste profile of certain , such as extending mint flavors. The U.S. approved neotame in 2002 as a general-purpose for use in a wide range of . In the , it received approval as E 961 in 2010. As of 2025, neotame is approved in more than 60 countries worldwide, reflecting its broad regulatory acceptance. A 2024 study suggested potential damage to gut cells at concentrations near the , though overall safety assessments by regulatory bodies remain positive.

History and development

Neotame was invented in the early by French chemists Claude Nofre and Jean-Marie Tinti at Claude Bernard University in , as part of their research into high-potency sweeteners derived from structures. This compound emerged from systematic modifications to , aiming for enhanced stability while maintaining intense , and was detailed in their seminal 2000 on its properties and utility. The rights to neotame were licensed to NutraSweet, a subsidiary of Monsanto Company, which drove its commercial development throughout the 1990s. Initial patent filings for the compound by Nofre and Tinti occurred in the early 1990s, with U.S. Patent No. 5,480,668 granted in 1996, covering its use as a sweetening agent. During this period, NutraSweet conducted key preclinical research phases, including evaluations of neotame's sweetness potency and stability in various food matrices, to support regulatory submissions. NutraSweet submitted a food additive petition to the U.S. (FDA) in late 1997, with formal review commencing in 1998, leading to approval on July 23, 2002, following an extensive evaluation of over 110 studies. In parallel, international assessments advanced: the Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated neotame in 2003–2004, establishing its safety profile, while the (EFSA) issued a positive scientific opinion in , culminating in EU authorization as a and flavor enhancer on January 19, 2010. In July 2025, EFSA re-evaluated neotame and established a higher of 10 mg/kg body weight per day. Post-approval expansions included China's Ministry of Health granting permission for use in foods and beverages on March 10, 2003, and Japan's Ministry of Health, Labour and Welfare approving it in 2010, with additional authorizations in over 30 countries, such as , , and , by 2015. More recently, by 2023–2025, neotame has been identified in unauthorized e-cigarette formulations, particularly flavored disposable vapes targeted at youth, prompting increased regulatory scrutiny from bodies like the FDA over its unapproved presence in tobacco products.

Chemistry

Structure and nomenclature

Neotame is an artificial sweetener with the molecular formula \ceC20H30N2O5\ce{C20H30N2O5}. It is a dipeptide composed of L-aspartic acid and L-phenylalanine methyl ester connected via a peptide bond, featuring a 3,3-dimethylbutyl group attached to the amino terminus of the aspartic acid residue through reductive amination. The systematic IUPAC name for neotame is NN-(N-(3,3-dimethylbutyl)-L-α-aspartyl)-L-phenylalanine 1-methyl ester, also expressed more formally as (3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid. The core structure of neotame can be textually represented as NN-(3,3-dimethylbutyl)-Asp-Phe-OMe, where Asp denotes the L-aspartyl residue with its side-chain , Phe-OMe is the L-phenylalanyl methyl , and the 3,3-dimethylbutyl (\ceCH2CH2C(CH3)3\ce{-CH2-CH2-C(CH3)3}) moiety provides a hydrophobic extension at the . This modification distinguishes neotame from its parent compound, (Asp-Phe-OMe), by introducing the bulky, nonpolar 3,3-dimethylbutyl group, which sterically hinders peptidases and stabilizes the linkage against enzymatic , thereby preventing the release of free . Neotame retains the (S) configuration—equivalent to the L-form—at both chiral centers (the α-carbons of and ), a stereochemical feature conserved from and critical for eliciting the sweet taste response. This specific L,L-stereochemistry ensures high sweetness potency, as alterations to the configuration diminish or eliminate the sweet sensation.

Synthesis

Neotame is primarily synthesized through the reductive alkylation of with 3,3-dimethylbutanal, employing as the . This one-step involves dissolving and the in a solvent such as or aqueous , followed by selective reduction of the intermediate under mild conditions to yield neotame with high efficiency. The reaction scheme can be represented as: Aspartame+(CH3)3CCH2CHO\ceNaBH3CNNeotame+byproducts\text{Aspartame} + (CH_3)_3CCH_2CHO \xrightarrow{\ce{NaBH3CN}} \text{Neotame} + \text{byproducts}
Add your contribution
Related Hubs
Contribute something
User Avatar
No comments yet.